IoT Blog | June 27, 2016
Getting new drugs and treatments to market quickly and effectively can be a challenge. A typical clinical trial can take as long as four years to complete and, in the end, only about 25 percent to 30 percent of treatments completed in a trial period are approved by the FDA for mass use. They also take a toll on patients, requiring patients to make countless trips to the doctor’s office or spend extended periods in a hospital, all so their reactions and symptoms can be closely monitored.
This is where the adoption of Internet of Things (IoT) and connected devices in healthcare make the clinical process easier for patients. In fact, there has been a 47 percent increase in the adoption of IoT solutions in the healthcare and pharmaceutical industries since 2014. IoT connected devices can provide clinical patients with the opportunity to be monitored and even treated in their homes. This not only improves quality of life for patients, but it also frees up face-to-face appointment time at hospitals and treatment centers for acute cases.
In clinical trials, connected devices can be used to monitor patients’ medication and long-term trends in their conditions. It also enables clinicians to remotely collect data from mobile devices that transmit readings from patients, which can provide doctors and nurses a comprehensive record at any time. With access to the data, healthcare providers can track patients’ progress, learn how a specific drug is working and recommend potential adjustments in treatment as needed.
To find out more, check out my full article in Health Data Management: http://bit.ly/28StuJz
By Andrew Morawski
Originally published on:https://www.linkedin.com/pulse/how-clinical-trials-could-get-boost-from-remote-andrew-morawski
Gartner has positioned Vodafone as a "Leader" in its Magic Quadrant for Managed M2M Services, Worldwide report 2017, for the fourth consecutive year